| Not Yet Recruiting | Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma Brain Stem Glioma | Phase 3 | 2027-06-01 |
| Not Yet Recruiting | Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma Brain Stem Glioma | Phase 3 | 2025-10-01 |
| Suspended | A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) Diffuse, Intrinsic Pontine Glioma | Phase 2 | 2016-04-13 |
| Withdrawn | Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma Optic Nerve Glioma | Phase 3 | 2011-12-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma CNS Tumor | Phase 2 | 1999-03-01 |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia Waldenstrom Macroglobulinemia | Phase 2 | 1999-02-18 |
| Terminated | Antineoplaston Therapy in Treating Patients With Meningioma Meningioma | Phase 2 | 1998-06-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma Non Hodgkin Lymphoma | Phase 2 | 1997-10-13 |
| Terminated | Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine Small Intestine Cancer | Phase 2 | 1997-08-13 |
| Terminated | Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma Neuroblastoma | Phase 2 | 1996-12-16 |
| Terminated | Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectoderma Primitive Neuroectodermal Tumor | Phase 2 | 1996-12-12 |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer Stage IV Prostate Cancer | Phase 2 | 1996-10-11 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stomach Cancer Stomach (Gastric) Cancer | Phase 2 | 1996-10-04 |
| Completed | Antineoplaston Therapy in Treating Children With Brain Tumors Childhood Brain Tumors | Phase 2 | 1996-09-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer Stage IV Adrenocortical Carcinoma | Phase 2 | 1996-08-21 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer | Phase 2 | 1996-08-21 |
| Completed | Antineoplaston Therapy in Treating Patients With Brain Tumors Refractory Brain Tumors | Phase 2 | 1996-07-01 |
| Completed | Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma Low Grade Astrocytomas | Phase 2 | 1996-07-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma Soft Tissue Sarcoma | Phase 2 | 1996-06-14 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva Cervical Cancer Stage IV, Vulvar Cancer, Stage IV | Phase 2 | 1996-06-03 |
| Completed | Antineoplaston Therapy in Treating Children With Visual Pathway Glioma Visual Pathway Glioma | Phase 2 | 1996-06-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus Adenocarcinoma of the Esophagus | Phase 2 | 1996-05-30 |
| Terminated | Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer Head and Neck Cancer | Phase 2 | 1996-05-06 |
| Terminated | Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder Stage IV Bladder Cancer | Phase 2 | 1996-05-06 |
| Terminated | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma Oligodendroglioma, Adult | Phase 2 | 1996-05-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma Non-hodgkins Lymphoma | Phase 2 | 1996-04-10 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer Stage IV Lung Cancer | Phase 2 | 1996-04-10 |
| Terminated | Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer Colon Cancer | Phase 2 | 1996-04-10 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer Stage IV Pancreatic Cancer | Phase 2 | 1996-04-10 |
| Terminated | Antineoplaston Therapy in Treating Patients With Multiple Myeloma Multiple Myeloma | Phase 2 | 1996-04-04 |
| Completed | Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors Childhood CNS Primitive Neuroectodermal Tumor | Phase 2 | 1996-04-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer Stage IV Lung Cancer | Phase 2 | 1996-03-27 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer Stage IV Kidney Cancer | Phase 2 | 1996-03-27 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Prostate Cancer | Phase 2 | 1996-03-27 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Melanoma Stage IV Melanoma | Phase 2 | 1996-03-27 |
| Terminated | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer Bronchial Alveolar; Tumor | Phase 2 | 1996-03-26 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer Stage IV Lung Cancer | Phase 2 | 1996-03-20 |
| Terminated | Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin Unknown Primary Carcinoma | Phase 2 | 1996-03-18 |
| Terminated | Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer Stage IV Breast Cancer | Phase 2 | 1996-03-18 |
| Completed | Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme Glioblastoma Multiforme of the Brain | Phase 2 | 1996-03-14 |
| Terminated | Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma Non-hodgkins Lymphoma | Phase 2 | 1996-03-11 |
| Terminated | Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Malignant Mesothelioma | Phase 2 | 1996-03-08 |
| Terminated | Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer Small Cell Lung Cancer Extensive Stage | Phase 2 | 1996-03-07 |
| Completed | Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma Low-Grade Lymphoma | Phase 2 | 1996-03-06 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer Stage III Ovarian Cancer, Stage IV Ovarian Cancer | Phase 2 | 1996-03-05 |
| Completed | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas Mixed Gliomas | Phase 2 | 1996-03-01 |
| Terminated | Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors Childhood Brain Tumor | Phase 2 | 1996-03-01 |
| Completed | Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma Anaplastic Astrocytoma | Phase 2 | 1996-03-01 |
| Completed | Antineoplaston Therapy in Treating Patients With Brain Stem Glioma Brain Stem Gliomas | Phase 2 | 1996-03-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma Low-Grade Astrocytoma, Nos | Phase 2 | 1996-03-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer Metastatic Prostate Cancer | Phase 2 | 1996-02-27 |
| Completed | Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors Malignant Brain Tumors | Phase 2 | 1996-02-01 |
| Terminated | Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System Rhabdoid Neoplasm of CNS | Phase 2 | 1996-02-01 |
| Completed | Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma Adult Brain Tumor | Phase 2 | 1995-04-01 |
| Completed | Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme Glioblastoma Multiforme of Brain | Phase 2 | 1995-03-14 |
| Terminated | Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma High Grade Glioma | Phase 2 | 1994-04-01 |
| Terminated | Antineoplaston Therapy in Treating Patients With Primary Liver Cancer Primary Liver Cancer | Phase 2 | 1977-03-21 |
| Terminated | Antineoplaston Therapy in Treating Patients With Ependymoma Ependymoma | Phase 2 | 1966-07-01 |
| Withdrawn | Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Stage IV Breast Cancer, Recurrent Breast Cancer | Phase 2 | — |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Colon Cancer Stage IV Colon Cancer, Recurrent Colon Cancer, Adenocarcinoma of the Colon | Phase 2 | — |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Adenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | — |
| Withdrawn | Antineoplaston Therapy in Treating Women With Advanced Breast Cancer Stage IV Breast Cancer, Recurrent Breast Cancer | Phase 2 | — |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma Primary Central Nervous System Lymphoma | Phase 2 | — |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respon Merkel Cell Carcinoma, Islet Cell Carcinoma, Neuroendocrine Carcinoma | Phase 2 | — |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma | Phase 2 | — |